missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD107a Mouse anti-Human, APC-R700, Clone: H4A3, BD
Mouse Monoclonal Antibody
Marque: BD Biosciences 565184
272.85 EUR valable jusqu'au 2025-12-31
Utilisez le code promo "25339" pour bénéficier de cette offre.
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
The H4A3 monoclonal antibody specifically binds to the heavily glycosylated 110 kDa Lysosomal-associated membrane protein 1, LAMP-1. LAMP-1 is a widely expressed intracellular antigen. It is also expressed on the surface of activated platelets, PHA-activated lymphocytes, cytotoxic T cells and NK cells, and some tumor cell lines, including U937 and KG1a. LAMP-1 has been shown to be a ligand for E-selectin-mediated cell adhesion. LAMP-1 and LAMP-2 (CD107b) are carriers for poly-N-acetyllactosamines and are able to display sialyl Le[x] termini.
This antibody was conjugated to BD Horizon APC-R700, which has been developed exclusively by BD Biosciences as a better alternative to Alexa Fluor™ 700. APC-R700 excites and emits at similar wavelengths to Alexa Fluor™ 700 yet exhibits significantly improved brightness. This dye can be excited by the red laser and detected with the same filter set as Alexa Fluor™ (eg, 730/45-nm filter).
Spécification
| CD107a | |
| Monoclonal | |
| APC-R700 | |
| Aqueous buffered solution containing BSA, protein stabilizer, glycerol, and ≤0.09% sodium azide. | |
| Human Adult Adherent Peripheral Blood Cells | |
| 50 Tests | |
| Primary | |
| Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. |
| Flow Cytometry, Immunocytochemistry | |
| H4A3 | |
| LAMP1; LAMP-1; LAMPA; LGP120 | |
| Mouse | |
| Affinity Purified | |
| RUO | |
| Human | |
| IgG1 κ |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
CD107a Mouse anti-Human, APC-R700, Clone: H4A3, BD > 50 Tests; APC-R700
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu
